Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Walnut peptide + phosphatidylserine is a combination dietary supplement consisting of walnut-derived peptides and the phospholipid phosphatidylserine. Walnut peptides are short chains of amino acids derived from walnuts, sometimes studied for their antioxidant, neuroprotective, or antifungal properties[3]. Phosphatidylserine is a naturally occurring phospholipid found in cell membranes, especially abundant in the brain. It plays roles in cell signaling and apoptosis and has been investigated for its potential to support cognitive function, memory, learning, and mood[1][2][5]. As a combination product, this supplement is marketed to promote brain health and cognitive performance by leveraging both the neuroactive properties of walnut peptides and the membrane-supporting effects of phosphatidylserine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on walnut peptide + phosphatidylserine.